Quibim

Quibim is a leading healthcare AI and medical imaging technology company specializing in AI-powered imaging biomarkers, radiomics, and precision medicine solutions. Headquartered in Valencia, Spain, the company develops advanced software that transforms MRI, CT, and PET scans into actionable clinical insights for hospitals, research institutions, pharmaceutical companies, and healthcare providers worldwide. Its AI platform helps clinicians improve diagnostic accuracy, accelerate disease detection, and support personalized treatment decisions across oncology, neurology, immunology, and metabolic diseases.

Quibim’s portfolio includes solutions such as QP-Prostate, QP-Brain, QP-Liver, and QP-Insights, which integrate seamlessly with existing radiology workflows and PACS systems. These products automate image analysis, quantify imaging biomarkers, and generate standardized reports that help physicians make faster and more informed clinical decisions. The company has earned regulatory clearances for several of its products and continues to expand its AI-powered imaging ecosystem for healthcare organizations worldwide.

One of Quibim’s key strengths is its focus on precision medicine. By combining artificial intelligence with large-scale medical imaging datasets, the company enables healthcare providers and life sciences organizations to identify disease patterns earlier, predict treatment outcomes, and improve patient care. Its technology is trusted by more than 230 healthcare centers globally, supporting clinical research, drug development, and routine diagnostic workflows.

Quibim also collaborates with leading healthcare organizations and technology companies to advance AI-driven diagnostics. The company has partnered with organizations including Microsoft to develop AI-powered virtual biopsy technologies and continues to invest heavily in innovation following a $50 million Series A funding round aimed at expanding its foundational AI models for medical imaging.

At AppsInsight, we recognize Quibim as one of the leading healthcare AI companies for organizations seeking advanced medical imaging software, radiomics platforms, and precision medicine solutions. Its strong expertise in artificial intelligence, imaging biomarkers, regulatory compliance, and clinical workflow integration makes it a trusted technology partner for hospitals, research institutions, and life sciences companies looking to modernize diagnostic imaging with AI.